Karen Andersen, CFA, strategist covering the biopharma industry for Morningstar, Inc., Chicago, which tracks 620,000 investment offerings. Morningstar.com
Many of the pandemic’s stock darlings have crashed, and they won’t rebound anytime soon because consumer habits have shifted. But if you dig deeper, you...
